Publikation

[Polycystic ovary syndrome--only relevant in reproductive medicine?]

Wissenschaftlicher Artikel/Review - 01.05.1999

Bereiche
PubMed

Zitation
Heim S, De Geyter C, Siegrist W, Bilz S, Keller U. [Polycystic ovary syndrome--only relevant in reproductive medicine?]. Therapeutische Umschau. Revue thérapeutique 1999; 56:271-5.
Art
Wissenschaftlicher Artikel/Review (Deutsch)
Zeitschrift
Therapeutische Umschau. Revue thérapeutique 1999; 56
Veröffentlichungsdatum
01.05.1999
ISSN (Druck)
0040-5930
Seiten
271-5
Kurzbeschreibung/Zielsetzung

The Polycystic Ovary Disease (PCOD) is one of the most common endocrine disorders in women with a prevalence of 5%. Affected women often consult a gynecologist because of menstrual irregularities, fertility problems or problems of androgen excess. However, PCOD is a metabolic disorder affecting multiple organs. Studies suggest that those women are at risk for developing several complications such as type II diabetes mellitus, hypertension, dyslipidemia and myocardial infarction. The risk to develop endometrial carcinoma is also elevated. To give adequate treatment to women with PCOD, an interdisciplinary approach of gynecologists together with endocrinologists specialized in metabolic and nutritional disorders at the University of Basel is presented. The work-up for diagnosis and assessment of risk factors is outlined. Goal of this interdisciplinary approach is an adequate evaluation of affected patients and their long-term follow-up to test if proposed interventions as weight loss, treatment of hyperinsulinemia, regulation of menstrual cycle and others can avoid long-term sequelae.